bpc-157 peptide what is it mechanism of action BPC 157 Gastric pentadecapeptide body protection compound
Description
We work only with long-established manufacturing partners and maintain clear documentation for every peptide we supply
8 ClinicalTrials.govNCT02637284 PCO-02: Phase I safety and pharmacokinetics trial of oral BPC-157 (early-stage human study)
Hospira: A Complete Brand Overview for Medical Buyers Jul 6th 2026 Many healthcare professionals use Hospira products daily without knowing the company behind the brand
Caution is warranted when using the peptide alongside other compounds, particularly those affecting metabolism or cardiovascular function
Bok J, Nieweg HO, Kroese WF, Faber JG, De Vries A
56, 2012, pp
